Moderna, Inc.
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Portfolio by asset class
Portfolio by asset class — Marketable equity securities ($M) ($M)
Moderna Portfolio by asset class: $2M in Q2 2026, down 66.7% from a year earlier. That is the lowest of the 14 quarters on record here.
Latest, Q2 2026
2
Period ended Jun 30, 2026
Change on a year earlier
-66.7%
6 in Q2 2025
History
14 quarters
Since Q1 2023
Sources
13
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 5 (Fair Value Hierarchy).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Portfolio by asset class — Marketable equity securities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 2 | -66.7% | Form 10-Q (filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 2 | -66.7% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 6 | -57.1% | Form 10-Q (filed 2026-07-31) ↗ |
| Q3 2025 | Sep 30, 2025 | 9 | -60.9% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 6 | -80.6% | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2025 | Mar 31, 2025 | 6 | -88.7% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 14 | -41.7% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2024 | Sep 30, 2024 | 23 | -47.7% | Form 10-Q (filed 2024-11-07) ↗ |
| Q2 2024 | Jun 30, 2024 | 31 | -59.7% | Form 10-Q (filed 2024-08-01) ↗ |
| Q1 2024 | Mar 31, 2024 | 53 | +29.3% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 24 | – | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2023 | Sep 30, 2023 | 44 | – | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 77 | – | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 41 | – | Form 10-Q (filed 2023-05-04) ↗ |
Cite this data
StockData. (2026). Moderna Portfolio by asset class ($M), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/afs-equity
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.